| 组别 | n | 第0周 | 第4周 | 第8周 | 第12周 |
HAMA | 治疗组 | 37 | 15.82 ± 6.88 | 14.60 ± 7.48 | 12.08 ± 6.48* | 11.36 ± 6.04**△△ |
对照组 | 35 | 16.42 ± 6.68 | 13.94 ± 5.84 | 15.20 ± 6.12 | 15.79 ± 5.94 | |
HAMD | 治疗组 | 37 | 12.89 ± 8.64 | 12.33 ± 7.92 | 10.74 ± 7.52△ | 11.12 ± 7.25△ |
对照组 | 35 | 13.25 ± 7.86 | 12.68 ± 7.54 | 13.65 ± 7.88 | 14.31 ± 8.04 | |
MMSE | 治疗组 | 37 | 26.35 ± 5.24 | 26.56 ± 5.38 | 26.22 ± 4.74 | 25.83 ± 4.21 |
对照组 | 35 | 26.64 ± 5.65 | 26.22 ± 4.76 | 25.44 ± 5.25 | 24.58 ± 5.63 | |
SCOPA-AUT | 治疗组 | 37 | 12.58 ± 6.23 | 10.21 ± 4.96△ | 8.98 ± 4.05**△△ | 8.64 ± 4.36**△△ |
对照组 | 35 | 12.08 ± 6.44 | 12.55 ± 5.54 | 13.33 ± 5.42 | 13.32 ± 5.23 | |
PDSS | 治疗组 | 37 | 98.63 ± 25.85 | 106.36 ± 27.45△ | 111.06 ± 27.16*△△ | 113.08 ± 30.42*△△ |
对照组 | 35 | 93.42 ± 32.82 | 91.71 ± 35.14 | 88.14 ± 30.63 | 87.25 ± 28.69 | |
PDQ39 | 治疗组 | 37 | 42.66 ± 21.03 | 42.36 ± 22.56 | 41.21 ± 19.84 | 38.25 ± 18.35△△ |
对照组 | 35 | 39.14 ± 19.45 | 40.42 ± 21.06 | 41.98 ± 21.05 | 45.04 ± 22.26* |